Bjorn-erik Bertelsen
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial.
Journal: Scientific reports
Published: July 15, 2024
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
Journal: Journal of the National Cancer Institute
Published: April 17, 2024
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane.
Journal: Breast cancer research and treatment
Published: January 19, 2024
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials.
Journal: Breast cancer research and treatment
Published: November 03, 2023
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: March 23, 2023
Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 08, 2021
Hormone References for Ultrasound Breast Staging and Endocrine Profiling to Detect Female Onset of Puberty.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 01, 2020
An Ultrasensitive Routine LC-MS/MS Method for Estradiol and Estrone in the Clinically Relevant Sub-Picomolar Range.
Journal: Journal of the Endocrine Society
Published: December 03, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026